Nasdaq: ADPT
Adaptive Biotechnologies insiders
The officers, directors and 10% owners of Adaptive Biotechnologies Corporation who hold the most stock, valued at the live ADPT price.
$28.05
ADPT today −$410K (−1.44%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 11
- Their ADPT stock
- $148M
- Market value
- $4.54B
- Held by ranked insiders
- 3.25%
Insiders by value of ADPT holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Chad M. Robins | CEO and Chairman | 2,080,518 | $58.4M | 1.29% | 2282nd |
| 2 | Harlan S Robins | Chief Scientific Officer | 812,058 | $22.8M | 0.50% | 4700th |
| 3 | Tycho Peterson | Chief Financial Officer | 531,553 | $14.9M | 0.33% | 6474th |
| 4 | Susan Bobulsky | Chief Commercial Officer, MRD | 387,475 | $10.9M | 0.24% | 8230th |
| 5 | Julie Rubinstein | President and COO | 377,802 | $10.6M | 0.23% | 8404th |
| 6 | Kyle Piskel | Chief Financial Officer | 256,725 | $7.2M | 0.16% | 11185th |
| 7 | Francis Lo | Chief People Officer | 223,367 | $6.3M | 0.14% | 12389th |
| 8 | Sharon Benzeno | Chief Commercial Ofc Imm Med | 221,278 | $6.2M | 0.14% | 12468th |
| 9 | Nitin Sood | Chief Commercial Officer, MRD | 214,808 | $6.0M | 0.13% | 12737th |
| 10 | Peter M Neupert | Director | 130,625 | $3.7M | <0.1% | 6914th |
| 11 | Kevin T. Conroy | Director | 22,968 | $644K | <0.1% | 9018th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Adaptive Biotechnologies; see each profile for the filing.